A Pathologist & Cytopathologist in Taiwan. Interests in Cancer biology, Cyto, Hema, Bioinformatics. Ex President of Taiwan Society Clinical Cytology.
Joined September 2013
- Tweets 4,548
- Following 347
- Followers 1,228
- Likes 19,612
428 Photos and videos
Pinned Tweet
27 Sep 2024
@IACytology @AshishC97225686
Thank Ash and Gary for hosting the IAC webinar. Allison and Carmen kindly helped the recording. I'm really thankful for over 200 online participants for those two talks. Grateful for the opportunity of doing contribution.
youtu.be/8v4-heveFio?si=316D…
3
13
1,385
Mark CC Chen, M.D. FIAC retweeted
Jun 12
HPV-DeepSeek improves the detection of residual HPV OPSCC!
#mgbpath
science.org/doi/10.1126/scit…
@MGBpathology
5
11
870
Mark CC Chen, M.D. FIAC retweeted
CC391. Gloomy Sunday case. Organ and diagnosis? When I show you the histological image (the day after tomorrow), it might become clearer to you. In my opinion, few tumors—if any—look like this after FNA of a XYZ tumor (adult). In a few years AI will spot it in seconds #cytopath
6
19
47
2,674
Mark CC Chen, M.D. FIAC retweeted
This study highlights the remarkable variability in cell block cellularity across laboratories and preparation methods 🤔 . There is an urgent need for better standardization 📋 and quality monitoring in routine #CytoPath practice. Take a look : onlinelibrary.wiley.com/doi/… #CytoJ
7
9
1,139
Mark CC Chen, M.D. FIAC retweeted
Jun 11
RAS-ing the bar in the treatment of KRAS-mutant cholangiocarcinoma dlvr.it/TT0SfW
1
19
49
2,830
Mark CC Chen, M.D. FIAC retweeted
Jun 12
Teaching "nuclear pleomorphism" to the incoming pathology interns next month - Hepatocellular Carcinoma. (FNA)
14
69
1,480
Mark CC Chen, M.D. FIAC retweeted
Jun 10
#MMR IHC interpretation guideline from #BAGP #pathology #IHC #MSI #pMMR #dMMR #pathognosis #genetics
1
24
50
2,359
Paul Bastard, MD, PhD, and Jean-Laurent Casanova, MD, PhD, describe the scientific foundations of a study implicating autoantibodies against interleukin-10 in persons with inflammatory bowel disease.
Read the editorial “Autoantibodies against Cytokines — From Infection to Inflammation”: nej.md/4e1EZ4s
ALT The image is a detailed infographic from the editorial "Autoantibodies against Cytokines — From Infection to Inflammation." It visually explains HLA risk allele and autoantibodies against interleukin-10 in inflammatory bowel disease.
2
73
221
19,033
Mark CC Chen, M.D. FIAC retweeted
🚨 The Comprehensive Review Course for Cytologists is an intensive, three-day experience.
🔬 Created by cytologists, for cytologists.
Tailored for:
• Practicing professionals
• Cytology students
Information - buff.ly/o1v13Qc
#cytopathology #cytologist
6
9
379
Mark CC Chen, M.D. FIAC retweeted
Jun 8
Efficacy, safety, and biomarker analysis of datopotamab deruxtecan in advanced non-small cell lung cancer: ICARUS-LUNG01 phase 2 study dlvr.it/TSxZ36
11
21
2,089
Mark CC Chen, M.D. FIAC retweeted
Preregister now for our next #IACwebinar: Thur, 18th June 14:00 CEST: Urinary Cytology, the Paris System, & Recent Molecular Advances presented by @MikouPanagiota cytology-iac.org/educational…
13
21
884
2026 Japan Korea Taiwan Joint Meeting for Gynecology Pathology has successfully ended tonight.
Most of us have had long term friendship and concerns about each other. Prof Ie-Ming Shin gave us a comprehensive talk for STIC and STIL.
5
146
Mark CC Chen, M.D. FIAC retweeted
May 31
The overall survival curves for Daraxonrasib in 2nd line advanced #PancreaticCancer leave no doubt how impactful this advance is for the field & for patients. Congratulations Brian Wolpin, @EileenMOReilly & @md_oberstein et al.
A seminal #ASCO26 plenary!
nejm.org/doi/full/10.1056/NE…
2
64
200
14,316
Presented at #ASCO26:
Among patients with 𝘙𝘌𝘛 fusion–positive non–small-cell lung cancer, adjuvant selpercatinib led to longer event-free survival than placebo. Adverse events of grade 3 or higher included elevated liver-enzyme levels. Full phase 3 LIBRETTO-432 trial results: nej.md/3Q3QcIo
@ASCO
ALT Graph depicting survival rates over time for patients using selpercatinib versus a placebo in early-stage RET fusion-positive non-small-cell lung cancer. The x-axis shows months since randomization, and the y-axis represents the percentage of patients. The logo for the New England Journal of Medicine is present.
71
232
25,698
Mark CC Chen, M.D. FIAC retweeted
CC389. Organ and diagnosis. #cytopath @kriyer68 @premcharles @DrRanasaleh @smlungpathguy @Histiocita @RibianszkyA @padmapathology1 @DrGeeONE
19
22
46
3,741
Mark CC Chen, M.D. FIAC retweeted
#OpenAccess! | Utility of whole-slide imaging for rapid evaluation of thyroid FNA: A multireader prospective study
acsjournals.onlinelibrary.wi…
#CytoPath @SaraAminMD @Gloria_SuraMD @Jenny_QiongGan
8
20
1,046
Mark CC Chen, M.D. FIAC retweeted
May 27
Qpap de la mano de @CDinares presidenta de la @SECitologia la excelencia NO es casualidad: se construye con control de calidad y estandarización #QualityControl #QualityAssurance #Screening #CytoPath #Standardization #QA #QC
8
13
566
Mark CC Chen, M.D. FIAC retweeted
#OpenAccess | Evaluation of 9 antibodies in a set of lung #adenocarcinoma cases, each with 4 matched effusion cell blocks, fixed in formalin, PreservCyt®, CytoLyt® and CytoRich™ Red, respectively.
acsjournals.onlinelibrary.wi…
#CytoPath @Mansour_cytopat
12
20
994
Mark CC Chen, M.D. FIAC retweeted
May 21
Today's @IACytology webinar shows many practical tips on analytical #cytopath issues and clinical impact. @Sinchita_Roy is a real expert (and molecular queen). @DianaEstherossi @sza_jhcyto @mdlozanoe @aakasharmand
1
9
21
653
We will have a one day cytology conference nearby Taipei main station on June 28.
It may be a good excuse for you enjoying seasonal Ai-Wen mangos in Taiwan this summer. The registration is still open for overseas. Look forward to seeing you. #taiwan #cytology @aakasharmand
1
4
10
453
Mark CC Chen, M.D. FIAC retweeted
New | Risk of malignancy for biliary cytology based on World Health Organization (WHO) reporting system for pancreaticobiliary cytopathology
acsjournals.onlinelibrary.wi…
#CytoPath @carliesigel
6
20
703